Álvaro Rodríguez-Lescure

15PUBLICATIONS

41CO-AUTHORS

Predictive and prognostic markersCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyCarbon capture engineering (excl. sequestration)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (15)

Sort by Publication Date:

|May 26, 2026

Sensitivity to endocrine therapy index predicts benefit from weekly adjuvant paclitaxel for hormone receptor-positive breast cancer in the GEICAM/9906 trial.

|Feb 24, 2026

Clinical subtypes in breast cancer patients with brain metastases from an ambispective registry of advanced breast cancer, GEICAM/2014-03 (RegistEM).

Sara López-Tarruella, Ángel Guerrero-Zotano, Silvia Antolín

|Nov 25, 2025

Correction: Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study.

Álvaro Rodríguez-Lescure, Javier Gallego, Pilar Garcia-Alfonso

|Sep 19, 2025

Reply to: From Discussion to Direction: Tumor Boards Need Clinical Editorial Leadership.

Miguel Borregón Rivilla, María Torrente, Álvaro Rodríguez-Lescure

|Jul 30, 2025

Revisiting Alma Ata: A Blueprint for Cancer Care.

Javier-David Benitez-Fuentes, Rodrigo Lastra Del Prado, Miguel Borregon-Rivilla

|Jun 05, 2025

Addressing Tumor Board Bad Habits and Risks: A Call for Rational Resource Management.

Miguel Borregón, María Torrente, Álvaro Rodríguez-Lescure

Pageof 3

Frequent Collaborators

5 joint publications

Javier-David Benitez-Fuentes

4 joint publications

Miguel Borregon Rivilla

2 joint publications

María Torrente

2 joint publications

Alicia de Luna Aguilar

Asia Ferrández-Arias

A J Muñoz Martín

P Jiménez-Fonseca

A Carmona-Bayonas

W Fraser Symmans

J Muñoz Langa

Frequent Collaborators

5 joint publications

Javier-David Benitez-Fuentes

4 joint publications

Miguel Borregon Rivilla

2 joint publications

María Torrente

2 joint publications

Alicia de Luna Aguilar